Johnson & Johnson has proposed a settlement of up to $5.5bn to resolve long-standing legal disputes regarding its baby powder. This payout aims to conclude a years-long battle involving approximately 76,000 plaintiffs. These individuals claimed that the company's talc-based products were responsible for causing ovarian cancer. The settlement is designed to address these extensive claims and bring a final resolution to the widespread litigation facing the drugmaker in the United States.
UK Cluster Comments